UNSPSC 51312105: Epinastine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H15N3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GFM415S5XL, chemically known as 9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride but more generally known as epinastine hydrochloride, which bears US NIH Compound Identifier 157313. European Medicines Agency schedules Epinastine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01910MIG.

UNSPSC 51312105 Epinastine hydrochloride is a Commodity code, but the most recent state and local solicitation tagged under this code does not align with its nominal scope—Seminole County, Florida issued IFB60459723LAS seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, neither of which is epinastine hydrochloride. The mismatch suggests either a coding error in the county's procurement system or that this Commodity code sees little relevant recent activity in state and local markets. State and local governments may purchase epinastine hydrochloride—an antihistamine ophthalmic agent—through health departments, county health systems, or school district health clinics for allergy treatment, but the source provides no concrete evidence of current solicitation activity under this code.

The single posting in the recent-opportunities block reflects Seminole County's procurement of opioid-overdose and drug-disposal products rather than pharmaceutical antihistamines. Without additional solicitations tagged to UNSPSC 51312105, geographic spread and issuing-body patterns cannot be reliably characterized. Business development teams should verify whether this code accurately reflects their target market or whether state and local health procurements for epinastine hydrochloride route through different taxonomy classifications or cooperative purchasing agreements not captured in the available data.